Literature DB >> 6876746

Degradation of extracellular matrix by larvae of Schistosoma mansoni. I. Degradation by cercariae as a model for initial parasite invasion of host.

J H McKerrow, W E Keene, K H Jeong, Z Werb.   

Abstract

We have examined the ability of cercariae of Schistosoma mansoni to degrade a model extracellular connective tissue matrix produced by rat vascular smooth muscle cells in culture. In this model, connective tissue macromolecules are present in the interactive framework that characterizes their structure in vivo. Cercariae were stimulated to degrade the matrix by skin lipid or linoleic acid. At the maximally stimulating concentration of linoleic acid (25 micrograms/cm2), 68% of the total matrix was degraded, including 57% of the glycoprotein, 79% of the elastin, and 8% of the collagen. Degradation of the matrix and transformation of cercariae to schistosomula began within minutes of exposure to maximally stimulating concentrations of linoleic acid. Degradation continued for 24 hours and was dependent on the number of cercariae. Some degradation occurred without exogenous stimulants but at a slower rate than with skin lipid or linoleic acid. Degradation of matrix was inhibited by alpha 1-proteinase inhibitor and soybean trypsin inhibitor. Ethylenediaminetetraacetic acid inhibited degradation by unstimulated but not linoleic acid-stimulated cercariae. Preacetabular gland secretions collected from cercariae also degraded the matrix with an activity 86% of that of live cercariae. Preacetabular gland proteolytic activity was also inhibited by alpha 1-proteinase inhibitor, soybean trypsin inhibitor, and ethylenediaminetetraacetic acid. The similar characteristics of matrix degradation by both live cercariae and cercarial preacetabular gland secretions support the idea that a proteinase secreted from cercarial preacetabular glands facilitates invasion of skin and connective tissue by these larvae. Degradation of elastin and glycoprotein constituents of extracellular matrix is probably essential for skin penetration.

Entities:  

Mesh:

Year:  1983        PMID: 6876746

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Strongyloides stercoralis excretory/secretory protein strongylastacin specifically recognized by IgE antibodies in infected human sera.

Authors:  Ravi Varatharajalu; Vijayalakshmi Parandaman; Momar Ndao; John F Andersen; Franklin A Neva
Journal:  Microbiol Immunol       Date:  2011-02       Impact factor: 1.955

2.  Proteinases from invasive larvae of the trematode parasite Schistosoma mansoni degrade connective-tissue and basement-membrane macromolecules.

Authors:  J H McKerrow; P Jones; H Sage; S Pino-Heiss
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

3.  A cysteine proteinase in the penetration glands of the cercariae of Tylodelphys excavata (Trematoda, Diplostomidae).

Authors:  T Moczon
Journal:  Parasitol Res       Date:  2006-10-19       Impact factor: 2.289

4.  Proteinase production by the parasitic cycle of the pathogenic fungus Coccidioides immitis.

Authors:  S Resnick; D Pappagianis; J H McKerrow
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

5.  Proteomic analysis of human skin treated with larval schistosome peptidases reveals distinct invasion strategies among species of blood flukes.

Authors:  Jessica Ingram; Giselle Knudsen; K C Lim; Elizabeth Hansell; Judy Sakanari; James McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

6.  The major neutral proteinase of Entamoeba histolytica.

Authors:  W E Keene; M G Petitt; S Allen; J H McKerrow
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

7.  Proteomic analysis of skin invasion by blood fluke larvae.

Authors:  Elizabeth Hansell; Simon Braschi; Katalin F Medzihradszky; Mohammed Sajid; Moumita Debnath; Jessica Ingram; K C Lim; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2008-07-16

Review 8.  Immune Evasion Strategies of Schistosomes.

Authors:  Jacob R Hambrook; Patrick C Hanington
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.